Tirzepatide is a medication used to aid in the treatment of type 2 diabetes and weight management
For example, the SELECT trial reported that semaglutide reduced the risk of MACE by 20% (Hazard Ratio (HR) 0.80, 95% confidence interval (CI) 0.720.90) in people with obesity but without diabetes, although several secondary outcomes did not reach statistical significance under hierarchical testing procedures
By contrast, first-time prescribing of AOMs increased 21.7% over the same period, from 0.56% to 0.69%
Current research presents a complex picture that requires careful interpretation, as studies have yielded mixed results depending on the specific agent studied, patient population, duration of treatment, and methodology employed
Use the 6-8 week gradual reduction protocol outlined earlier
This CPT code for RSV vaccine is specific to the products dosage and is used to report the administration of this quantity of the monoclonal antibody